Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$167,442,621
+$107,941,807 QoQ
Shares Held
685,005
+138.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.04453252166043.ToString("F0")%
Shared 0.9554674783395741.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$904,428
CallShares
3,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $1,050,650,050 across 16 Drug Manufacturers - General names. JNJ ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
250,310 | $230,227,627 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
685,005 | $167,442,621 | |
| 3 | AMGN |
Amgen Inc
|
441,940 | $155,496,587 | |
| 4 | ABBV |
AbbVie Inc.
|
497,947 | $108,298,491 | |
| 5 | MRK |
Merck & Co., Inc.
|
895,792 | $107,754,818 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
501,840 | $69,941,439 | |
| 7 | PFE |
Pfizer Inc
|
1,925,435 | $54,066,214 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
708,717 | $42,983,685 |
All Filings in JNJ
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $904,428 | 3,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $167,442,621 | 685,005 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,500,814 | 287,513 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $620,850 | 3,000 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $129,794 | 700 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $46,485,164 | 250,702 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,300,721 | 218,008 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,892,509 | 186,279 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $31,497,511 | 217,795 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,282,531 | 186,860 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $24,592,150 | 168,255 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,219,995 | 153,107 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $24,487,803 | 156,232 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $21,309,092 | 136,816 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $19,663,775 | 118,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,720,065 | 114,323 | Shares | Defined | 2023-05-23 | |
| 2022-12-31 | $18,470,523 | 104,560 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $15,005,596 | 91,856 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $12,520,845 | 70,536 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,326,850 | 86,480 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $14,098,733 | 82,415 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $8,326,940 | 51,560 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,422,388 | 38,985 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,085,905 | 24,861 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,079,454 | 19,567 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,378,655 | 15,977 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,991,179 | 14,159 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,721,867 | 13,131 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||